Agastiya Biotech Receives FDA Orphan Drug Designation for AB001 for Pancreatic Cancer and Acute Myeloid Leukemia (AML)

Agastiya Biotech and Vopec Pharmaceuticals announce that the US FDA has granted Orphan Drug Designations for Pancreatic Cancer and AML for its novel small molecule, AB001.